Home / Recalls / Central Admixture Pharmacy Services, Inc. / D-0947-2023

D-0947-2023 Class II Terminated

Recalled by Central Admixture Pharmacy Services, Inc. — Phoenix, AZ

Recall Details

Product Type
Drugs
Report Date
August 9, 2023
Initiation Date
July 14, 2023
Termination Date
March 28, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
77,554 Syringes.

Product Description

rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheonix, AZ, NDC 72196-6010-1.

Reason for Recall

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Distribution Pattern

Nationwide in the USA

Code Information

Lot: 36-238805, 36-238806, 36-238808, 36-238809, 36-238810, 36-238811, Exp. 7/10/2023; 36-239229, 36-239319, 36-239320, 36-239321, 36-239322, Exp. 7/11/2023; 36-239453, 36-239454, 36-239455, Exp. 7/12/2023; 36-239851, 36-239852, Exp. 7/13/2023; 36-240204, Exp. 7/16/2023; 36-240509, 36-240510, 36-240511, Exp. 7/17/2023; 36-241263, 36-241266, Exp. 7/19/2023; 36-241362, 36-241363, 36-241365, Exp. 7/20/2023; 36-241880, 36-241881, 36-241882, Exp. 7/23/2023; 36-242376, 36-242377, Exp. 7/24/2023; 36-242603, 36-242618, Exp. 7/25/2023; 36-242643, 36-242644, 36-242645, Exp. 7/26/2023; 36-243534, 36-243535, Exp. 7/30/2023; 36-243831, Exp. 7/31/2023; 36-244831, 36-244833, 36-244841, 36-244842, 36-244845, 36-244855, Exp. 8/01/2023; 36-245803, Exp. 8/02/2023; 36-246288, 36-246289, 36-246290, 36-246291, 36-246369, Exp. 8/03/2023; 36-246775, 36-246776, 36-246777, 36-246778, 36-246779, Exp. 8/07/2023; 36-248327, Exp. 8/13/2023; 36-249504, 36-249505, Exp. 8/18/2023; 36-249685, 36-249686, 36-249687, Exp. 8/20/2023; 36-249746, 36-249748, 36-249749, 36-249751, 36-249752, 36-249753, Exp. 8/21/2023; 36-250070, 36-250071, Exp. 8/22/2023; 36-250416, 36-250417, 36-250418, 36-250419, 36-250420, 36-250421, Exp. 8/23/2023; 36-251027, 36-251028, Exp. 8/24/2023; 36-251566, 36-251567, 36-251568, Exp. 8/28/2023; 36-251772, 36-251773, 36-251774, 36-251775, Exp. 8/29/2023; 36-252323, Exp. 8/31/2023

Other recalls by Central Admixture Pharmacy Services, Inc.

  • D-0272-2025 Class I — PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only (February 20, 2025)
  • D-0007-2024 Class II — PHENYLephrine in 0.9% sodium chloride, 1,000 mcg/10 mL, (100 mcg/mL), 10 mL syri (September 21, 2023)
  • D-0009-2024 Class II — fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx onl (September 21, 2023)
  • D-0016-2024 Class II — fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volu (September 21, 2023)
  • D-0020-2024 Class II — fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS I (September 21, 2023)
  • D-0013-2024 Class II — fentaNYL in 0.9% sodium chloride, 2,500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx (September 21, 2023)
  • D-0028-2024 Class II — HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, (September 21, 2023)
  • D-0018-2024 Class II — midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Centra (September 21, 2023)
  • D-0027-2024 Class II — HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, R (September 21, 2023)
  • D-0025-2024 Class II — fentaNYL, 1,250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixtur (September 21, 2023)